Bryn Mawr Trust CO Novartis Ag Transaction History

Bryn Mawr Trust CO

  • $5.25 Billion
  • Q1 2025

A detailed history of Bryn Mawr Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Bryn Mawr Trust CO holds 41,459 shares of NVS stock, worth $4.64 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
41,459
Previous 41,432 0.07%
Holding current value
$4.64 Million
Previous $4.03 Million 14.64%
% of portfolio
0.09%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
BUY
$97.14 - $115.57 $2,622 - $3,120
27 Added 0.07%
41,459 $4.62 Million
Q4 2024

Jan 28, 2025
BUY
$96.78 - $117.18 $2,709 - $3,281
28 Added 0.07%
41,432 $4.03 Million
Q3 2024

Nov 25, 2024
BUY
$106.13 - $120.89 $3.19 Million - $3.63 Million
30,016 Added 263.58%
41,404 $4.76 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $2,477 - $2,820
-26 Reduced 0.23%
11,388 $1.1 Million
Q3 2023

Nov 15, 2023
SELL
$94.73 - $105.13 $22,640 - $25,126
-239 Reduced 2.05%
11,414 $1.16 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $30,901 - $35,039
-334 Reduced 2.79%
11,653 $1.18 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $17,686 - $20,511
221 Added 1.88%
11,987 $1.1 Million
Q4 2022

Feb 10, 2023
SELL
$75.55 - $92.52 $3,777 - $4,626
-50 Reduced 0.42%
11,766 $1.07 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $2,536 - $2,966
-34 Reduced 0.29%
11,816 $898,000
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $94,852 - $110,437
-1,178 Reduced 9.04%
11,850 $1 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $3,685 - $4,168
-46 Reduced 0.35%
13,028 $1.14 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $5,658 - $6,257
-71 Reduced 0.54%
13,074 $1.14 Million
Q3 2021

Oct 26, 2021
SELL
$81.78 - $95.14 $36,801 - $42,813
-450 Reduced 3.31%
13,145 $1.08 Million
Q2 2021

Jul 29, 2021
SELL
$85.24 - $94.15 $52,252 - $57,713
-613 Reduced 4.31%
13,595 $1.24 Million
Q1 2021

Apr 23, 2021
SELL
$83.5 - $98.47 $29,642 - $34,956
-355 Reduced 2.44%
14,208 $1.22 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $86,813 - $105,006
-1,112 Reduced 7.09%
14,563 $1.38 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $63,412 - $70,252
-772 Reduced 4.69%
15,675 $1.36 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $8,093 - $9,110
100 Added 0.61%
16,447 $1.44 Million
Q1 2020

May 08, 2020
BUY
$70.67 - $99.01 $205,579 - $288,020
2,909 Added 21.65%
16,347 $1.35 Million
Q4 2019

Feb 11, 2020
SELL
$84.35 - $95.37 $66,805 - $75,533
-792 Reduced 5.57%
13,438 $1.27 Million
Q3 2019

Oct 24, 2019
SELL
$85.54 - $94.26 $55,515 - $61,174
-649 Reduced 4.36%
14,230 $1.24 Million
Q2 2019

Aug 15, 2019
SELL
$75.4 - $92.8 $242,637 - $298,630
-3,218 Reduced 17.78%
14,879 $1.36 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $212,854 - $243,459
-2,826 Reduced 13.51%
18,097 $1.74 Million
Q4 2018

Feb 15, 2019
SELL
$73.66 - $82.02 $159,400 - $177,491
-2,164 Reduced 9.37%
20,923 $1.8 Million
Q3 2018

Nov 15, 2018
SELL
$66.94 - $77.43 $197,205 - $228,108
-2,946 Reduced 11.32%
23,087 $1.99 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $93,275 - $105,418
1,437 Added 5.84%
26,033 $1.97 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $37,940 - $45,356
-539 Reduced 2.14%
24,596 $1.99 Million
Q4 2017

Aug 28, 2019
SELL
$72.33 - $77.64 $13,236 - $14,208
-183 Reduced 0.72%
25,135 $2.11 Million
Q4 2017

Feb 15, 2018
SELL
$72.33 - $77.64 $292,791 - $314,286
-4,048 Reduced 13.78%
25,318 $2.13 Million
Q3 2017

Aug 28, 2019
SELL
$74.14 - $77.27 $14,457 - $15,067
-195 Reduced 0.66%
29,366 $2.52 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $2.19 Million - $2.28 Million
29,561
29,561 $2.54 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email